Crossref
Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia
Ankyra Medical Journal · 2024
DOI: 10.51271/ankmj-0011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ankyra Medical Journal, 2024. Verfasst von Şükrü Alperen Korkmaz.
Abstract (Originalsprache)
Bipolar disorder (BD) and schizophrenia (SCZ) are chronic mental disorders with mood and psychotic episodes, respectively, which significantly affect functioning and quality of life.
Zitieren
APA
Korkmaz, Ş. A. (2024). Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia. Ankyra Medical Journal. https://doi.org/10.51271/ankmj-0011
Vancouver
Korkmaz ŞA. Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia. Ankyra Medical Journal. 2024. doi:10.51271/ankmj-0011
BibTeX
@article{Korkmaz2024,
author = {Korkmaz, Şükrü Alperen},
title = {Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia},
journal = {Ankyra Medical Journal},
year = {2024},
doi = {10.51271/ankmj-0011}
}
EUVIMED